Circadian rhythm of cytochrome P4502E1 and its effect on disposition kinetics of chlorzoxazone in rats
- PMID: 17651723
- DOI: 10.1016/j.ejphar.2007.06.032
Circadian rhythm of cytochrome P4502E1 and its effect on disposition kinetics of chlorzoxazone in rats
Abstract
The aim of this report is to study the circadian rhythm of cytochrome P4502E1 (CYP2E1) and its effect on the disposition kinetics of chlorzoxazone in male Wistar rats. The rats were housed under a 12-h light/dark cycle (lights from 9:00 to 21:00) with food and water ad libitum for 3 months. It was found that the expression of microsomal CYP2E1 mRNA in the liver during the dark phase was significantly lower than during the light phase, whereas the content of CYP2E1 protein and its hydroxylation activity were significantly higher. Therefore, chlorzoxazone 20 mg/kg was intravenously administered at 12:00 (light phase group) or 24:00 (dark phase group) to determine the effect on the disposition kinetics. The value of the area under the plasma concentration-time curve from 0 to 8 h (AUC(0-8 h)) of chlorzoxazone showed no significant difference between the two groups. However, the value of chlorzoxazone half-life in plasma of the light phase group was significant longer than the dark phase group. The AUC(0-8 h) of 6-hydroxychlorzoxazone, a metabolite formed from chlorzoxazone mainly by CYP2E1, was significantly higher in the dark phase than in the light phase. In conclusion, microsomal CYP2E1 shows a substantial circadian variation in rats, and this was associated with a decrease of chlorzoxazone half life, and an increase of 6-hydroxychlorzoxazone production. Therefore, the temporal variations of therapeutic response and toxicological effects may have to be taken into consideration for other xenobiotics that are predominantly metabolized by CYP2E1, particularly those with a short half-life.
Similar articles
-
Obesity-induced increase of CYP2E1 activity and its effect on disposition kinetics of chlorzoxazone in Zucker rats.Biochem Pharmacol. 2007 Jan 1;73(1):155-62. doi: 10.1016/j.bcp.2006.09.006. Epub 2006 Sep 14. Biochem Pharmacol. 2007. PMID: 17049493
-
Effect of the acute-phase response on the pharmacokinetics of chlorzoxazone and cytochrome P-450 2E1 in vitro activity in rats.Drug Metab Dispos. 1999 Sep;27(9):1074-7. Drug Metab Dispos. 1999. PMID: 10460809
-
Impaired 6-hydroxychlorzoxazone elimination in patients with kidney disease: Implication for cytochrome P450 2E1 pharmacogenetic studies.Clin Pharmacol Ther. 2003 Dec;74(6):555-68. doi: 10.1016/j.clpt.2003.09.003. Clin Pharmacol Ther. 2003. PMID: 14663458 Clinical Trial.
-
Cytochrome CYP2E1 phenotyping and genotyping in the evaluation of health risks from exposure to polluted environments.Toxicol Lett. 2001 Oct 15;124(1-3):71-81. doi: 10.1016/s0378-4274(00)00287-3. Toxicol Lett. 2001. PMID: 11684359 Review.
-
Nrf2 and antioxidant defense against CYP2E1 toxicity.Expert Opin Drug Metab Toxicol. 2009 Oct;5(10):1223-44. doi: 10.1517/17425250903143769. Expert Opin Drug Metab Toxicol. 2009. PMID: 19671018 Review.
Cited by
-
The hepatic circadian clock modulates xenobiotic metabolism in mice.J Biol Rhythms. 2014 Aug;29(4):277-87. doi: 10.1177/0748730414544740. J Biol Rhythms. 2014. PMID: 25238856 Free PMC article.
-
Timing in drug absorption and disposition: The past, present, and future of chronopharmacokinetics.Br J Pharmacol. 2020 May;177(10):2215-2239. doi: 10.1111/bph.15017. Epub 2020 Mar 20. Br J Pharmacol. 2020. PMID: 32056195 Free PMC article. Review.
-
Sex differences in the circadian variation of cytochrome p450 genes and corresponding nuclear receptors in mouse liver.Chronobiol Int. 2013 Nov;30(9):1135-43. doi: 10.3109/07420528.2013.805762. Epub 2013 Aug 8. Chronobiol Int. 2013. PMID: 23926955 Free PMC article.
-
Molecular Aspects of Circadian Pharmacology and Relevance for Cancer Chronotherapy.Int J Mol Sci. 2017 Oct 17;18(10):2168. doi: 10.3390/ijms18102168. Int J Mol Sci. 2017. PMID: 29039812 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources